Integra Therapeutics
PrivateLast Round
VC Round
Sep 8, 2025
Total Funding Raised
$27.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Integra Therapeutics is a biotechnology company that creates next-generation gene writing tools to improve the safety and efficacy of advanced therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Integra Therapeutics Comparables
Compare Integra Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tessera Therapeutics | 81% | |
| T-CURX GmbH | 78% | |
| Demeetra AgBio | 77% |
Integra Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 8, 2025 | ||||
| Grant | Jul 17, 2024 | ||||
| Early Funding | Sep 8, 2023 | ||||
| Seed | Mar 30, 2022 | ||||
| Seed | Dec 2, 2021 |
Key People
Founding team and executive leadership
Integra Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| CDTI Innvierte | Early Funding, VC Round |
| Pompeu Fabra University | VC Round, Seed |
| Center for Technological Development and Innovation | VC Round |
| Takeda Ventures | VC Round, Early Funding, Seed |
| Invivo Partners | VC Round, Early Funding, Seed |
| Columbus Venture Partners | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 32% MoM, reaching 3.5K.
- May 16, 2026
Monthly visitors increased 93% MoM.
Recent news
Latest coverage and updates
- hiresOct 16, 2026
Integra hires Simon Dew as chief business officer to build partnerships for FiCAT, its preclinical gene-writing platform, in Spain.
Integra Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Integra Therapeutics's valuation, stock price, and market status.
Is Integra Therapeutics a public or private company?
Integra Therapeutics is a private company.
What is the current stock price of Integra Therapeutics?
Integra Therapeutics is a private company, so its shares have no public market price. Caplight tracks Integra Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Integra Therapeutics worth (valuation)?
Valuation information for Integra Therapeutics is not publicly available.
Can I buy Integra Therapeutics stock?
Integra Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Integra Therapeutics's last funding round?
Integra Therapeutics's most recent funding round was VC Round on September 8, 2025.
Who are the main investors in Integra Therapeutics?
Key investors in Integra Therapeutics include CDTI Innvierte, Center for Technological Development and Innovation, Takeda Ventures, Invivo Partners, AdBio partners.
Will Integra Therapeutics IPO soon?
No public IPO plans have been announced for Integra Therapeutics.
How can I track Integra Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Integra Therapeutics's shares on secondary markets.